Wednesday, November 18, 2026 Vol. I · No. 6
Health · Via STAT

STAT+: Seven burning questions about the FDA’s post-Overton future

Image: STAT

STAT tackles the most important questions about the FDA's uncertain future.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk